Morgan Stanley
WGS icon

Morgan Stanley’s GeneDx Holdings WGS Stock Holding History

Morgan Stanley’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.8M Buy
988,297
+456,062
+86% +$25.9M ﹤0.01% 1930
2026
Q1 		$34.2M Buy
532,235
+26,144
+5% +$2.38M ﹤0.01% 2475
2025
Q4 		$65.8M Buy
506,091
+38,279
+8% +$5.25M ﹤0.01% 1822
2025
Q3 		$50.4M Sell
467,812
-19,258
-4% -$2.1M ﹤0.01% 1999
2025
Q2 		$45M Buy
487,070
+274,604
+129% +$21.6M ﹤0.01% 2024
2025
Q1 		$18.8M Sell
212,466
-366
-0.2% -$31.8K ﹤0.01% 2758
2024
Q4 		$16.4M Buy
212,832
+14,479
+7% +$1.01M ﹤0.01% 2955
2024
Q3 		$8.42M Sell
198,353
-39,188
-16% -$1.32M ﹤0.01% 3556
2024
Q2 		$6.21M Sell
237,541
-555,940
-70% -$10.5M ﹤0.01% 3712
2024
Q1 		$7.24M Buy
793,481
+9,353
+1% +$56.1K ﹤0.01% 3597
2023
Q4 		$2.16M Buy
784,128
+780,461
+21,283% +$1.81M ﹤0.01% 4459
2023
Q3 		$13.3K Sell
3,667
-6,211
-63% -$34K ﹤0.01% 6620
2023
Q2 		$58.9K Buy
9,878
+2,646
+37% +$20.9K ﹤0.01% 6150
2023
Q1 		$87.1K Buy
7,232
+469
+7% +$6.25K ﹤0.01% 6068
2022
Q4 		$58.9K Buy
6,763
+4,205
+164% +$92.7K ﹤0.01% 6220
2022
Q3 		$74K Sell
2,558
-7,361
-74% -$337K ﹤0.01% 6228
2022
Q2 		$413K Buy
9,919
+5,257
+113% +$357K ﹤0.01% 5514
2022
Q1 		$472K Sell
4,662
-117,392
-96% -$13M ﹤0.01% 5436
2021
Q4 		$18M Buy
122,054
+11,509
+10% +$2.57M ﹤0.01% 2274
2021
Q3 		$27.7M Buy
110,545
+109,650
+12,251% +$37.7M ﹤0.01% 1757
2021
Q2 		$414K Sell
895
-1,754
-66% -$753K ﹤0.01% 5640
2021
Q1 		$1.3M Buy
2,649
+1,482
+127% +$771K ﹤0.01% 4562
2020
Q4 		$425K Buy
+1,167
New +$407K ﹤0.01% 5179

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Morgan Stanley's WGS Position: Q2 2026 in Review

Morgan Stanley increased its GeneDx Holdings (WGS) stake by 86% in Q2 2026, buying an estimated $25.9M and bringing the position to 988,297 shares worth $67.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Morgan Stanley first reported a position in WGS in Q4 2020 and has held it in 23 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Morgan Stanley held 988,297 shares of GeneDx Holdings worth $67.8M as of Q2 2026.
  • Morgan Stanley bought 456,062 GeneDx Holdings shares in Q2 2026, an estimated $25.9M.
  • GeneDx Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #1930 holding.
  • Morgan Stanley first reported a position in GeneDx Holdings in Q4 2020 and has held it in 23 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.